We are live on ! Find out more
RCYC

Richard C. Young & Co Portfolio holdings

AUM $1.36B
1-Year Est. Return 66.41%
This Fund
S&P 500
This Quarter Est. Return
+2.21%
1 Year Est. Return
+66.41%
3 Year Est. Return
+137.43%
5 Year Est. Return
+151.84%
10 Year Est. Return
+342.18%
AUM
$823M
AUM Growth
+$26.1M
Cap. Flow
+$20.3M
Cap. Flow %
2.46%
Top 10 Hldgs %
29.39%
Holding
82
New
8
Increased
49
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$12M
2
TGT icon
Target
TGT
+$11.3M
3
NVDA icon
NVIDIA
NVDA
+$10.6M
4
KO icon
Coca-Cola
KO
+$9.02M
5
QCOM icon
Qualcomm
QCOM
+$7.04M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$12.7M
2
UL icon
Unilever
UL
+$11.3M
3
SJM icon
J.M. Smucker
SJM
+$7.52M
4
AVA icon
Avista
AVA
+$3.66M
5
SNY icon
Sanofi
SNY
+$3.49M

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Industrials 13.19%
3 Miscellaneous 12.31%
4 Energy 11.29%
5 Consumer Staples 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
26
Kinder Morgan
KMI
$68.7B
$14.3M 1.74%
720,744
+19,352
+3% +$369K
WMB icon
27
Williams Companies
WMB
$89.1B
$14M 1.7%
329,898
+11,757
+4% +$472K
AFL icon
28
Aflac
AFL
$57.8B
$14M 1.7%
156,420
+3,146
+2% +$270K
VLO icon
29
Valero Energy
VLO
$112B
$13.3M 1.62%
85,157
-1,457
-2% -$235K
APD icon
30
Air Products & Chemicals
APD
$64.9B
$13.2M 1.6%
51,029
+471
+0.9% +$119K
WMT icon
31
Walmart Inc
WMT
$850B
$13.1M 1.59%
193,212
+7,435
+4% +$468K
NVDA icon
32
NVIDIA
NVDA
$5.27T
$12.9M 1.57%
+104,389
New +$10.6M
EMR icon
33
Emerson Electric
EMR
$84.9B
$12.8M 1.55%
116,092
+1,293
+1% +$143K
PFE icon
34
Pfizer
PFE
$158B
$12.3M 1.49%
439,189
+21,683
+5% +$597K
ITW icon
35
Illinois Tool Works
ITW
$76.4B
$12.2M 1.48%
51,480
-781
-1% -$193K
IBM icon
36
IBM
IBM
$229B
$11.3M 1.38%
65,615
+318
+0.5% +$55.3K
GD icon
37
General Dynamics
GD
$96.3B
$11M 1.34%
37,983
+736
+2% +$216K
HSY icon
38
Hershey
HSY
$34.8B
$10.8M 1.31%
58,808
-64
-0.1% -$12.4K
MCD icon
39
McDonald's
MCD
$179B
$10.7M 1.31%
42,175
+641
+2% +$170K
FTS icon
40
Fortis
FTS
$27.8B
$10.7M 1.3%
275,027
-15,202
-5% -$600K
MDT icon
41
Medtronic
MDT
$116B
$10.7M 1.3%
135,598
-177
-0.1% -$14.5K
JNJ icon
42
Johnson & Johnson
JNJ
$640B
$10.7M 1.3%
72,979
+275
+0.4% +$40.9K
TGT icon
43
Target
TGT
$70.8B
$10.7M 1.29%
+71,948
New +$11.3M
CMI icon
44
Cummins
CMI
$76.6B
$10.2M 1.24%
36,937
+462
+1% +$132K
UNP icon
45
Union Pacific
UNP
$169B
$10.2M 1.24%
45,183
+850
+2% +$199K
JPM icon
46
JPMorgan Chase
JPM
$947B
$10.2M 1.24%
50,389
+2,463
+5% +$482K
PNC icon
47
PNC Financial Services
PNC
$97.4B
$9.48M 1.15%
60,950
+1,235
+2% +$191K
KO icon
48
Coca-Cola
KO
$380B
$9.28M 1.13%
+145,790
New +$9.02M
HD icon
49
Home Depot
HD
$308B
$8.77M 1.07%
25,469
+5
+0% +$1.71K
CL icon
50
Colgate-Palmolive
CL
$69.2B
$8.14M 0.99%
83,929
+4,421
+6% +$408K

Similar funds

Richard C. Young & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Richard C. Young & Co held 82 positions worth $823M, up 3.3% from $797M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Richard C. Young & Co's Q2 2024 filing shows 8 new, 49 increased, 18 reduced and 5 closed positions. Its largest new stake was Target: 71,948 shares worth $10.7M. The largest sale was Novartis, an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Industrials and Miscellaneous.

  • Richard C. Young & Co's largest Q2 2024 buy was Target: 71,948 shares worth $10.7M.
  • Richard C. Young & Co added most to Apple in Q2 2024, an estimated $12M increase.
  • Richard C. Young & Co's biggest Q2 2024 reduction was J.M. Smucker, cutting an estimated $7.52M.
  • Richard C. Young & Co fully exited Novartis in Q2 2024, selling an estimated $12.7M.
  • Richard C. Young & Co's ten largest holdings make up 29% of its $823M portfolio in Q2 2024.
  • Richard C. Young & Co opened 8 new positions and closed 5 in Q2 2024.
  • Richard C. Young & Co's portfolio value rose 3.3% quarter-over-quarter to $823M.

Based on Richard C. Young & Co's 13F filing for Q2 2024, filed 8 Aug 2024.